220 related articles for article (PubMed ID: 34873031)
1. Stress Signal ULBP4, an NKG2D Ligand, Is Upregulated in Multiple Sclerosis and Shapes CD8
Carmena Moratalla A; Carpentier Solorio Y; Lemaitre F; Farzam-Kia N; Levert A; Zandee SEJ; Lahav B; Guimond JV; Haddad E; Girard M; Duquette P; Larochelle C; Prat A; Arbour N
Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34873031
[TBL] [Abstract][Full Text] [Related]
2. The NKG2D ligand ULBP4 binds to TCRgamma9/delta2 and induces cytotoxicity to tumor cells through both TCRgammadelta and NKG2D.
Kong Y; Cao W; Xi X; Ma C; Cui L; He W
Blood; 2009 Jul; 114(2):310-7. PubMed ID: 19436053
[TBL] [Abstract][Full Text] [Related]
3. Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4.
Zöller T; Wittenbrink M; Hoffmeister M; Steinle A
Front Immunol; 2018; 9():620. PubMed ID: 29651291
[TBL] [Abstract][Full Text] [Related]
4. Four novel ULBP splice variants are ligands for human NKG2D.
Cao W; Xi X; Wang Z; Dong L; Hao Z; Cui L; Ma C; He W
Int Immunol; 2008 Aug; 20(8):981-91. PubMed ID: 18544572
[TBL] [Abstract][Full Text] [Related]
5. Specific alterations in NKG2D
Carmena Moratalla A; Carpentier Solorio Y; Lemaître F; Farzam-Kia N; Da Cal S; Guimond JV; Haddad E; Duquette P; Girard JM; Prat A; Larochelle C; Arbour N
Mult Scler Relat Disord; 2023 Mar; 71():104542. PubMed ID: 36716577
[TBL] [Abstract][Full Text] [Related]
6. NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis.
Legroux L; Moratalla AC; Laurent C; Deblois G; Verstraeten SL; Arbour N
Front Immunol; 2019; 10():154. PubMed ID: 30787931
[TBL] [Abstract][Full Text] [Related]
7. Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells.
Cerboni C; Ardolino M; Santoni A; Zingoni A
Blood; 2009 Mar; 113(13):2955-64. PubMed ID: 19124832
[TBL] [Abstract][Full Text] [Related]
8. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of the NKG2D ligand ULBP4 may be an indicator of poor prognosis in patients with nasopharyngeal carcinoma.
Xu Y; Zhou L; Zong J; Ye Y; Chen G; Chen Y; Liao X; Guo Q; Qiu S; Lin S; Chen H; Pan J
Oncotarget; 2017 Jun; 8(26):42007-42019. PubMed ID: 28159927
[TBL] [Abstract][Full Text] [Related]
10. NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8
Vadstrup K; Galsgaard ED; Jensen H; Lanier LL; Ryan JC; Chen SY; Nolan GP; Vester-Andersen MK; Pedersen JS; Gerwien J; Jensen T; Bendtsen F
Exp Mol Pathol; 2017 Aug; 103(1):56-70. PubMed ID: 28684217
[TBL] [Abstract][Full Text] [Related]
11. NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis.
Saikali P; Antel JP; Newcombe J; Chen Z; Freedman M; Blain M; Cayrol R; Prat A; Hall JA; Arbour N
J Neurosci; 2007 Jan; 27(5):1220-8. PubMed ID: 17267578
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
[TBL] [Abstract][Full Text] [Related]
13. MICAgen Mice Recapitulate the Highly Restricted but Activation-Inducible Expression of the Paradigmatic Human NKG2D Ligand MICA.
Kim Y; Born C; Bléry M; Steinle A
Front Immunol; 2020; 11():960. PubMed ID: 32582150
[TBL] [Abstract][Full Text] [Related]
14. Release of Soluble Ligands for the Activating NKG2D Receptor: One More Immune Evasion Strategy Evolved by HIV-1 ?
Giuliani E; Vassena L; Cerboni C; Doria M
Curr Drug Targets; 2016; 17(1):54-64. PubMed ID: 26122035
[TBL] [Abstract][Full Text] [Related]
15. Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis.
Saikali P; Antel JP; Pittet CL; Newcombe J; Arbour N
J Immunol; 2010 Nov; 185(10):5693-703. PubMed ID: 20926794
[TBL] [Abstract][Full Text] [Related]
16. The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease.
Stojanovic A; Correia MP; Cerwenka A
Front Immunol; 2018; 9():827. PubMed ID: 29740438
[TBL] [Abstract][Full Text] [Related]
17. The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology.
Secchiari F; Nuñez SY; Sierra JM; Ziblat A; Regge MV; Raffo Iraolagoitia XL; Rovegno A; Ameri C; Secin FP; Richards N; Ríos Pita H; Vitagliano G; Rico L; Mieggi M; Frascheri F; Bonanno N; Blas L; Trotta A; Friedrich AD; Fuertes MB; Domaica CI; Zwirner NW
Oncoimmunology; 2022; 11(1):2104991. PubMed ID: 35936986
[TBL] [Abstract][Full Text] [Related]
18. Chimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibition.
Song DG; Ye Q; Santoro S; Fang C; Best A; Powell DJ
Hum Gene Ther; 2013 Mar; 24(3):295-305. PubMed ID: 23297870
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.
Eisele G; Wischhusen J; Mittelbronn M; Meyermann R; Waldhauer I; Steinle A; Weller M; Friese MA
Brain; 2006 Sep; 129(Pt 9):2416-25. PubMed ID: 16891318
[TBL] [Abstract][Full Text] [Related]
20. [Expression and biological function of ULBP4 in Rosetta-gamiTMB(DE3) and mAb preparation].
Cao W; Hao ZY; Xi XY; Kong Y; Ma C; Cui LX; He W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Mar; 23(3):242-5. PubMed ID: 17343792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]